A New Breast Cancer Subtype
Clinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
Home > Patients, Caregivers, and Advocates > Research > A New Breast Cancer Subtype
Clinical trial results are changing care for people with metastatic breast cancer that expresses low levels of HER2 protein.
Your donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now